CAIRO, Stefano Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.567
AS - Asia 1.902
EU - Europa 734
SA - Sud America 373
AF - Africa 65
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.644
Nazione #
US - Stati Uniti d'America 3.480
SG - Singapore 719
CN - Cina 423
BR - Brasile 316
VN - Vietnam 225
HK - Hong Kong 166
IT - Italia 133
DE - Germania 124
UA - Ucraina 102
SE - Svezia 86
GB - Regno Unito 84
TR - Turchia 81
BD - Bangladesh 74
FR - Francia 53
JP - Giappone 49
CA - Canada 44
RU - Federazione Russa 44
IN - India 42
FI - Finlandia 35
MX - Messico 32
ID - Indonesia 27
ZA - Sudafrica 22
AR - Argentina 17
MA - Marocco 17
PK - Pakistan 16
ES - Italia 15
EC - Ecuador 12
IQ - Iraq 12
PL - Polonia 12
CO - Colombia 10
NL - Olanda 10
UZ - Uzbekistan 9
AT - Austria 8
IR - Iran 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
KR - Corea 7
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
IL - Israele 4
KE - Kenya 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DO - Repubblica Dominicana 3
JO - Giordania 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
CL - Cile 2
CR - Costa Rica 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MG - Madagascar 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
KI - Kiribati 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 6.644
Città #
Singapore 422
Ashburn 414
Fairfield 322
San Jose 289
Woodbridge 286
Beijing 163
Santa Clara 161
Houston 158
Chandler 157
Hong Kong 157
Jacksonville 132
Seattle 131
Ann Arbor 126
Wilmington 121
Cambridge 102
New York 80
Ho Chi Minh City 76
Dallas 74
Los Angeles 53
Hanoi 50
Tokyo 49
Izmir 47
Council Bluffs 37
Nanjing 37
Boardman 36
Dearborn 35
Lauterbourg 30
Princeton 29
São Paulo 29
Shanghai 28
Ferrara 22
Mexico City 22
Bremen 21
Montreal 20
San Diego 19
Jakarta 18
Falls Church 16
London 16
Orem 16
Brooklyn 15
Chicago 15
Milan 15
Munich 15
Da Nang 14
The Dalles 14
Augusta 13
Chennai 13
Nanchang 13
Stockholm 13
Toronto 13
Phoenix 12
Rio de Janeiro 12
Johannesburg 11
Warsaw 11
Atlanta 10
Curitiba 10
Hebei 10
San Francisco 10
Ankara 9
Haiphong 9
Manchester 9
Moscow 9
Nuremberg 9
Tashkent 9
Columbus 8
Guangzhou 8
Poplar 8
Rome 8
Shenyang 8
Belo Horizonte 7
Boston 7
Campinas 7
Denver 7
Des Moines 7
Jiaxing 7
Ardabil 6
Frankfurt am Main 6
Hangzhou 6
Mumbai 6
Ninh Bình 6
Norwalk 6
Addison 5
Amsterdam 5
Baghdad 5
Biên Hòa 5
Bologna 5
Brasília 5
Buffalo 5
Changsha 5
Fes 5
Guarulhos 5
Osasco 5
Redwood City 5
Brno 4
Bến Tre 4
Cairo 4
Caracas 4
Casalecchio Di Reno 4
Charlotte 4
Guayaquil 4
Totale 4.500
Nome #
Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score 258
Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy 257
Functional genomics of the B-box gene family reveals a possible role in subcellular compartmentalization 233
Activation of Wnt and Myc signaling in hepatoblastoma 231
Functional characterization of the OFD1 protein reveals a nuclear localization and physical interaction with subunits of a chromatin remodeling complex 228
Reprogramming of miRNA networks in cancer and leukemia 225
CA3-Classification de l’hépatoblastome par l'étude en microarray du profil d’expression génétique 219
Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? 215
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress 213
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 209
The genomic landscape of hepatoblastoma and their progenies with HCC-like features 206
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 202
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts 201
How transient becomes stable: an epigenetic switch linking liver inflammation and tumorigenesis 197
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer 190
Preferential localization of tyrosine-phosphorylated paxillin in focal adhesions 183
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models 182
LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis 180
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer 172
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis 171
The tripartite motif family identifies cell compartments 170
The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription 166
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features 160
Myc target miRs and liver cancer: small molecules to get Myc sick 156
Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein 147
Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties 141
Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes 134
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 132
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer 126
A KRAS-responsive long non-coding RNA controls microRNA processing 122
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management 120
Expression profiling and CGH array as prognostic tools in hepatoblastoma 98
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 89
null 83
Establishment and characterization of circulating tumor cell-derived xenografts in non-small cell lung cancer 83
Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment 83
SSEA4 AND ST3GAL2 AS CHEMOTHERAPEUTIC DRUG RESPONSE BIOMARKERS 82
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma 81
null 76
The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models 68
Understanding breast cancer resistance to chemotherapy: Characterization of cancer cell sub-populations in residual and relapsed tumors 53
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model 51
Tbx3 is a downstream target of the Wnt/$\beta$-catenin pathway and a critical mediator of $\beta$-catenin survival functions in liver cancer 51
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression 47
Preclinical evaluation of the PARP inhibitor niraparib and cytotoxic chemotherapy alone or in combination in a panel of 25 triple-negative breast cancer PDX models: Relevance of BRCA mutations, HRD status and other biomarkers 45
Totale 6.736
Categoria #
all - tutte 31.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 20 21 16 7 31 30 12 26 11 38 33 68
2022/2023361 30 33 27 36 70 45 11 29 43 5 20 12
2023/2024231 14 26 7 6 7 52 5 19 6 10 7 72
2024/2025960 21 14 60 20 124 72 61 72 167 94 171 84
2025/20262.784 265 113 247 280 449 158 412 139 223 259 171 68
2026/202744 44 0 0 0 0 0 0 0 0 0 0 0
Totale 6.736